報價延遲最少15分鐘:2025/09/16 18:02 EDT
盤後時段
|
||||
|
2.8885 
|
|
|
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
2.79
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.29/-0.24
|
|
企業價值
262.25M
|
| 資產負債 |
|
每股賬面淨值
0.02
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
26.92M
|
|
每股收益
0.32
|
|
同行比較
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
報價延遲最少15分鐘：2025/09/16 18:02 EDT
同行比較之報價最少15分鐘延遲
|
業務概覽
|
|||
| Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, andinformation solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream. |
